Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
Shah BD, Cassaday RD, Park JH, Houot R, Oluwole OO, Logan AC, Boissel N, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff PJ, Jeyakumar D, Mao D, Adhikary S, Zhou L, Schuberth PC, Damico Khalid R, Ghobadia A. Shah BD, et al. Among authors: adhikary s. J Immunother Cancer. 2023 Aug;11(8):e007118. doi: 10.1136/jitc-2023-007118. J Immunother Cancer. 2023. PMID: 37648261 Free PMC article.
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Dong J, Adhikary S, Zhou L, Schuberth PC, Faghmous I, Masouleh BK, Houot R. Shah BD, et al. Among authors: adhikary s. J Hematol Oncol. 2022 Dec 10;15(1):170. doi: 10.1186/s13045-022-01379-0. J Hematol Oncol. 2022. PMID: 36494725 Free PMC article.
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer.
Santegoets SJ, Welters MJP, Schrikkema DS, Freriks MR, Kok H, Weissbrich B, van den Branden A, Linnemann C, Schumacher TN, Adhikary S, Bendle G, van der Burg SH. Santegoets SJ, et al. Among authors: adhikary s. Cancer Immunol Immunother. 2023 Jun;72(6):1553-1565. doi: 10.1007/s00262-022-03350-x. Epub 2022 Dec 16. Cancer Immunol Immunother. 2023. PMID: 36526910 Free PMC article.
Protocol for an evaluation of the initiation of an integrated longitudinal outpatient care model for severe chronic non-communicable diseases (PEN-Plus) at secondary care facilities (district hospitals) in 10 lower-income countries.
Adler AJ, Wroe EB, Atzori A, Bay N, Bekele W, Bhambhani VM, Nkwiro RB, Boudreaux C, Calixte D, Chiwanda Banda J, Coates MM, Dagnaw WW, Domingues K, Drown L, Dusabeyezu S, Fenelon D, Gupta N, Ssinabulya I, Jain Y, Kalkonde Y, Kamali I, Karekezi C, Karmacharya BM, Koirala B, Makani J, Manenti F, Mangwiro A, Manuel B, Masiye JK, Goma FM, Mayige MT, McLaughlin A, Mensah E, Salipa NM, Mutagaywa R, Mutengerere A, Ngoga G, Patiño M, Putoto G, Ruderman T, Salvi D, Sesay S, Taero F, Tostão E, Toussaint S, Bukhman G, Mocumbi AO; PEN-Plus Partnership study group. Adler AJ, et al. BMJ Open. 2024 Jan 30;14(1):e074182. doi: 10.1136/bmjopen-2023-074182. BMJ Open. 2024. PMID: 38296295 Free PMC article.
339 results